Impact of Graves’ Disease and Antithyroid Drug Therapy on Bone Mineral Density – Pathophysiological Mechanisms and Clinical Relevance

Graves’ disease is an autoimmune disease characterized by excessive thyroid hormone production. One of the consequences of that state can be a decrease in bone mineral density (BMD). Graves’ disease is often treated with antithyroid drugs (ATD) as first line therapy, which can lead to disease rem...

Descripció completa

Dades bibliogràfiques

Autors principals:	Dunja Mudri, Tomislav Kizivat, Martina Smolić, Ivica Mihaljević, Robert Smolić, Nikola Raguž Lučić, Ines Bilić-Ćurčić
Format:	Artigo
Idioma:	Inglês
Publicat:	Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2022-01-01
Col·lecció:	Acta Clinica Croatica
Matèries:	Graves’ disease Bone Mineral Density Wnt Signaling Pathway Sclerostin Dickkopf 1
Accés en línia:	https://hrcak.srce.hr/file/428520
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!